No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
324 |
4. Check minimum number of eventsNone |
324 |
5. Include endpointsNone |
324 |
6. Filter based on genotype QC (FinnGen only) |
288 |
Control definitions (FinnGen only)
- Control exclude
- H7_LIDLACRIMALORBIT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H04
- Name in latin
- Dacryoadenitis
Similar endpoints
↥List of similar endpoints to
Dacryoadenitis
based on the number of shared cases.
Similar with more cases:
- Disorders of lacrimal system
- Disorders of eyelid, lacrimal system and orbit
- Diseases of the eye and adnexa
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2212 | 1511 | 693 |
| Only index persons | 1950 | 1344 | 606 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.02 |
| Only index persons | 0.04 | 0.05 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 53.96 | 56.86 | 47.52 |
| Only index persons | 51.95 | 55.26 | 44.61 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 288 | 203 | 85 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.04 |
| Median age at first event (years) | 54.59 | 54.03 | 55.94 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 297
- Matched controls
- 2970
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H04.0
ICD-10 Finland
Dacryoadenitis
+∞
307.7
270
*
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
401.3
90.0
86
*
CCD60
NOMESCO Finland
Transnasal dacryocystorhinostomy
+∞
60.5
56
*
H04.4
ICD-10 Finland
Chronic inflammation of lacrimal passages
+∞
58.3
54
*
H04.10
ICD-10 Finland
Dry eye syndrome
9.8
55.8
74
97
H04.3
ICD-10 Finland
Acute and unspecified inflammation of lacrimal passages
122.6
48.5
51
5
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
+∞
47.2
44
*
CCD50
NOMESCO Finland
Dacryocystorhinostomy with insertion of tube
+∞
26.4
25
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
3.3
22.8
152
717
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
3.2
21.4
176
927
H01.0
ICD-10 Finland
Blepharitis
6.0
19.1
36
67
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
5.0
19.0
45
103
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
190.9
17.7
18
*
TCC30
NOMESCO Finland
Intubation of lacrimal canaliculus/duct
190.9
17.7
18
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.2
17.6
88
341
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.7
16.4
41
98
S01GX01
ATC
cromoglicic acid; ophthalmic
3.1
16.3
86
343
H02AB06
ATC
prednisolone; systemic
2.7
15.8
175
1025
36800
ICD-8 Finland
Inflammation of lachrymal glands and ducts, Dacryadenitis acuta. Abscessus glandulae lacrimalis
+∞
15.8
15
*
H02.4
ICD-10 Finland
Ptosis of eyelid
56.1
13.9
16
*
H57.1
ICD-10 Finland
Ocular pain
6.3
13.8
24
41
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
6.0
13.1
24
43
H02AB04
ATC
methylprednisolone; systemic
3.1
12.9
64
243
H02.3
ICD-10 Finland
Blepharochalasis
21.0
11.3
16
8
J01DB01
ATC
cefalexin; oral
3.2
10.8
261
2051
F29
ICPC
Eye symptom/complaint other
3.2
10.7
48
171
F03
ICPC
Eye discharge
3.7
10.4
34
99
L04AA06
ATC
mycophenolic acid; systemic
17.5
10.0
15
9
H16.0
ICD-10 Finland
Corneal ulcer
4.4
9.9
26
64
L04AX03
ATC
methotrexate; systemic
3.2
9.5
41
143
S01AD03
ATC
aciclovir; ophthalmic
5.0
9.2
20
42
L04AX01
ATC
azathioprine; systemic
5.1
9.0
19
39
ZXE00
NOMESCO Finland
One hour or less
2.1
8.9
130
799
R01AD08
ATC
fluticasone; nasal
2.2
8.9
97
532
ZXA00
NOMESCO Finland
Right side
2.2
8.9
93
502
Z3229
NOMESCO Finland
Other healthcare associate professional
3.1
8.5
37
129
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.0
8.5
41
152
J01FF01
ATC
clindamycin; systemic
2.2
8.4
92
503
36802
ICD-8 Finland
Inflammation of lachrymal glands and ducts, Obstructio, stenosis viarum lacrimalium
+∞
8.4
8
*
36801
ICD-8 Finland
Inflammation of lachrymal glands and ducts, Dacryadenitis chronica
+∞
8.4
8
*
R06AE07
ATC
cetirizine; oral
2.0
8.1
140
908
A03CA02
ATC
clidinium and psycholeptics; oral
3.4
7.7
28
87
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
3.3
7.6
30
99
A05AA02
ATC
ursodeoxycholic acid; oral
8.7
7.4
15
18
CCA30
NOMESCO Finland
Incision of lacrimal sac
+∞
7.3
7
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.8
7.2
39
154
D07AC01
ATC
betamethasone; topical
2.0
7.0
114
716
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.7
7.0
41
169
UDM02
NOMESCO Finland
Sinoscopy
7.0
6.9
16
24
J01FA10
ATC
azithromycin; systemic
1.9
6.9
175
1271
H04.2
ICD-10 Finland
Epiphora
41.0
6.8
8
*
F73
ICPC
Eye infection/inflammation other
6.7
6.7
16
25
UJF32
NOMESCO Finland
Coloscopy
2.0
6.7
86
495
L04AD01
ATC
ciclosporin; systemic
12.6
6.6
11
9
XCK00
NOMESCO Finland
Perimetry
3.2
6.6
27
91
H16.8
ICD-10 Finland
Other keratitis
71.3
6.4
7
*
S01XA18
ATC
ciclosporin; ophthalmic
71.3
6.4
7
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
6.4
117
758
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
6.4
147
1026
R06AE09
ATC
levocetirizine; oral
2.4
6.3
48
223
A02BA04
ATC
nizatidine; systemic
2.9
6.3
30
110
R01AD09
ATC
mometasone; nasal
1.9
6.3
137
938
H05.0
ICD-10 Finland
Acute inflammation of orbit
+∞
6.3
6
*
H02.2
ICD-10 Finland
Lagophthalmos
+∞
6.3
6
*
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
+∞
6.3
6
*
CCD40
NOMESCO Finland
Percutaneous dacryocystorhinostomy
+∞
6.3
6
*
H20.1
ICD-10 Finland
Chronic iridocyclitis
27.3
6.3
8
*
H00.03
ICD-10 Finland
Preseptal cellulite in the eyelid
27.3
6.3
8
*
H26.4
ICD-10 Finland
After-cataract
2.5
6.1
40
174
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
23
59
4.14
8.32
1.5
1.6
0.08
0.01
iu/ml
—
8
9
85
454
2.22
8.23
1.4
1.3
2.70
9.73
u/ml
2.11
35
188
241
1923
2.34
7.75
6.9
4.1
12.47
12.75
mm/h
0.13
229
1782
89
501
2.11
7.46
1.4
1.3
19.14
33.23
iu/ml
1.27
24
158
167
1175
1.96
7.43
6.3
4.5
35.54
35.56
g/l
0.02
157
1112
190
1429
1.91
6.59
5.4
4.0
0.00
0.01
estimate
0.50
38
286
187
1412
1.88
6.26
5.3
3.9
0.00
0.00
estimate
-0.00
41
310
187
1418
1.86
6.11
5.4
3.9
0.00
5.98
estimate
0.50
42
314
237
1970
2.01
5.50
11.3
7.6
78.35
79.27
u/l
0.11
228
1862
8
6
13.65
5.10
1.1
1.0
—
—
—
0
0
27
113
2.53
4.46
2.4
1.6
20.36
8.00
iu/ml
—
7
27
234
1991
1.83
4.34
5.5
4.5
14.82
14.92
pmol/l
0.29
219
1812
37
186
2.13
4.05
2.0
1.6
—
—
—
0
0
168
1322
1.62
4.04
7.2
7.2
1.22
1.21
mmol/l
0.08
148
1146
11
23
4.92
3.91
1.0
1.1
—
—
—
0
0
277
2527
2.43
3.78
25.6
18.8
3.98
3.96
mmol/l
0.74
272
2467
12
29
4.27
3.74
2.5
1.2
—
—
—
0
0
160
1260
1.58
3.72
4.2
3.1
111.58
111.05
ug/l
0.01
153
1163
67
425
1.74
3.67
2.4
1.9
—
—
—
0
0
101
716
1.62
3.64
2.5
2.2
2.88
3.05
mg/l
0.37
93
612
152
1188
1.57
3.62
3.1
2.6
81.06
77.85
nmol/l
0.76
144
1070
92
638
1.64
3.62
1.5
1.3
2.07
1.63
u/ml
0.13
27
161
17
63
2.80
3.55
2.1
1.6
—
—
—
0
0
51
301
1.84
3.55
2.3
1.9
—
—
—
0
0
14
47
3.08
3.46
1.6
1.5
—
—
—
0
0
260
2334
1.91
3.44
6.8
5.5
1.74
1.90
mu/l
1.75
246
2142
7
10
7.14
3.38
4.9
1.8
—
—
—
0
0
7
10
7.14
3.38
1.0
1.0
1636.14
1464.10
miu/ml
—
7
10
116
865
1.56
3.32
3.7
3.1
7.89
7.37
mmol/l
0.49
101
741
151
1201
1.52
3.19
6.9
6.1
1.22
1.22
mmol/l
0.16
145
1115
138
1080
1.52
3.12
5.4
3.9
0.09
0.01
estimate
0.43
35
256
16
62
2.67
3.10
1.9
1.5
—
—
—
0
0
51
314
1.75
3.09
2.3
1.8
—
—
—
0
0
20
87
2.39
3.08
2.8
1.4
—
—
—
0
0
271
2487
2.02
3.04
22.9
15.8
19.06
24.15
mg/l
2.18
240
2041
281
2614
2.39
3.04
16.8
11.3
24.12
24.42
u/l
0.13
274
2541
177
1473
1.50
2.90
12.8
9.0
3.85
4.12
e9/l
1.09
158
1274
281
2621
2.34
2.90
28.6
20.5
76.84
75.41
umol/l
0.43
281
2587
265
2422
1.87
2.89
5.3
4.9
4.64
4.63
mmol/l
0.06
249
2240
268
2461
1.91
2.84
6.2
5.6
2.71
2.68
mmol/l
0.21
253
2272
110
836
1.50
2.79
4.7
3.9
12.71
8.31
mg/mmol
0.34
69
529
169
1400
1.48
2.79
7.8
6.2
10.61
11.05
umol/l
0.30
160
1340
16
66
2.51
2.76
2.1
3.8
0.30
1.10
index
—
10
40
18
79
2.36
2.73
1.4
1.8
4.13
3.01
iu/l
—
6
22
105
796
1.49
2.68
4.2
3.0
0.28
0.42
e6/l
0.55
81
582
83
599
1.54
2.67
2.5
1.7
0.91
1.32
mg/l
1.11
64
484
254
2316
1.67
2.50
7.1
6.2
39.76
39.26
mmol/mol
0.37
239
2169
106
815
1.47
2.49
6.2
4.0
0.00
0.00
estimate
-0.00
37
295
17
76
2.31
2.49
1.4
1.2
—
—
—
0
0
103
788
1.47
2.48
3.2
3.4
1122.39
1561.33
ng/l
0.80
91
671
260
2388
1.71
2.45
5.6
5.0
5.83
5.93
mmol/l
0.71
239
2184
6
12
5.08
2.41
1.3
3.5
329.00
1039.58
u/ml
—
6
12
41
256
1.70
2.37
6.8
3.0
1.34
2.10
mmol/l
0.98
36
221
17
78
2.25
2.36
1.8
1.5
—
—
—
0
0
230
2067
1.50
2.23
28.8
20.3
331.36
331.35
g/l
0.00
230
2060
11
41
2.75
2.23
1.6
1.5
—
—
—
0
0
106
830
1.43
2.22
4.1
2.5
58.06
60.54
u/l
0.15
96
772
12
48
2.56
2.21
1.4
1.4
—
192.00
—
0
5
66
472
1.51
2.19
1.7
1.7
—
—
—
0
0
54
371
1.56
2.14
5.3
6.3
104.15
104.18
mmol/l
0.02
54
371
147
1226
1.39
2.12
21.6
14.0
1.29
1.25
inr
0.33
126
1019
8
25
3.26
2.11
1.4
1.4
—
—
—
0
0
260
2411
1.63
2.07
5.2
4.8
1.47
1.50
mmol/l
0.37
243
2225
258
2390
1.61
2.04
20.5
15.3
80.26
80.14
ml/min/173m2
0.03
237
2215
15
70
2.20
2.02
1.4
1.1
—
—
—
0
0
15
70
2.20
2.02
1.4
1.1
—
—
—
0
0
118
955
1.39
2.01
3.0
3.3
2.37
2.35
mmol/l
0.45
110
869
55
386
1.52
1.99
2.6
1.8
29.05
29.36
s
0.15
55
375
10
39
2.62
1.96
1.3
1.6
—
—
—
0
0
5
11
4.60
1.95
1.2
2.1
4.98
4.44
kpa
—
5
11
5
11
4.60
1.95
1.2
2.1
9.56
10.61
kpa
—
5
11
22
121
1.88
1.94
1.1
1.1
—
—
—
0
0
99
784
1.39
1.90
4.7
3.4
0.00
0.01
estimate
0.74
36
246
17
86
2.04
1.89
1.2
1.2
—
—
—
0
0
191
1684
1.38
1.87
4.9
3.2
46.35
45.90
u/l
0.02
183
1590
83
640
1.41
1.86
2.7
2.8
320.58
337.56
umol/l
0.77
72
559
6
17
3.58
1.84
1.8
3.6
288.33
805.35
mg
—
6
17
103
825
1.38
1.84
3.9
2.0
115.01
211.52
u/l
2.92
96
784
25
148
1.75
1.77
2.8
2.4
0.56
0.64
%
0.67
25
148
6
18
3.38
1.75
1.2
1.2
—
—
—
0
0
16
82
2.01
1.73
1.3
1.3
—
—
—
0
0
15
75
2.05
1.73
1.6
1.3
—
—
—
0
0
11
48
2.34
1.72
1.4
1.5
—
—
—
0
0
124
1035
1.34
1.68
2.0
1.9
1.36
1.34
mmol/l
0.12
100
878
6
19
3.20
1.67
1.3
1.0
—
—
—
0
0
25
151
1.72
1.66
2.8
2.4
1.22
1.25
%
0.05
25
151
7
25
2.84
1.66
1.3
1.2
—
—
—
0
0
11
49
2.29
1.65
3.7
2.4
8.43
6.89
pmol/l
0.23
11
49
29
183
1.65
1.65
1.6
1.3
433.07
136.99
u/ml
1.16
12
75
5
14
3.61
1.62
2.8
3.3
107.00
102.29
%
—
5
14
6
20
3.04
1.59
1.3
1.1
—
—
—
0
0
25
154
1.68
1.56
2.0
2.1
—
—
—
0
0
37
252
1.53
1.55
3.6
2.4
91.73
30.86
u/l
0.58
30
207
6
21
2.89
1.51
1.3
1.9
—
—
—
0
0
6
21
2.89
1.51
1.3
1.9
—
—
—
0
0
6
21
2.89
1.51
1.3
1.9
—
—
—
0
0
105
869
1.32
1.47
4.3
3.0
32.56
29.51
u/l
0.30
96
830
7
28
2.54
1.46
1.4
1.4
272.71
353.41
mu/l
—
7
22
21
126
1.72
1.44
1.3
1.3
—
—
—
0
0
5
16
3.16
1.44
1.4
1.7
73.80
72.50
umol/l
—
5
16
5
16
3.16
1.44
1.2
4.7
60.00
198.38
nmol/l
—
5
16
29
191
1.57
1.41
2.1
2.1
—
—
—
0
0
9
41
2.23
1.38
1.1
1.1
—
—
—
0
0
35
243
1.50
1.35
5.8
6.4
1.31
1.28
mmol/l
0.08
35
236
12
61
2.01
1.34
1.7
1.3
—
—
—
0
0
14
76
1.88
1.32
3.4
2.9
—
—
—
0
0
6
24
2.53
1.31
1.7
1.3
—
—
—
0
0
5
18
2.81
1.29
1.4
1.5
8.40
13.83
u/l
—
5
18
9
44
2.08
1.28
1.8
1.2
—
—
—
0
0
9
44
2.08
1.28
1.8
1.2
—
—
—
0
0
41
298
1.44
1.27
6.0
2.6
7.01
7.39
umol/l
0.06
32
258
5
19
2.66
1.22
1.8
1.4
—
—
—
0
0
38
276
1.43
1.19
4.1
3.4
—
—
—
0
0
68
548
1.31
1.13
2.0
1.8
476.93
40798676.68
pmol/l
0.76
57
451
168
1514
1.25
1.12
3.7
3.1
—
—
—
0
0
66
532
1.31
1.10
5.9
5.0
2.45
2.77
ug/l
0.17
58
474
133
1171
1.25
1.08
2.4
2.1
94.85
97.76
pmol/l
0.28
79
618
244
2305
1.33
1.08
4.4
4.2
1.25
1.26
mmol/l
0.09
226
2111
28
196
1.47
1.07
2.5
2.5
57.62
64.23
ml/min/173m2
0.43
13
82
7
33
2.15
1.06
1.1
1.6
—
—
—
0
0
140
1242
1.24
1.06
3.0
2.7
—
—
estimate
—
0
0
13
75
1.77
1.04
2.0
3.8
1.49
1.76
ratio
—
8
41
5
22
2.29
1.04
2.4
1.9
—
—
—
0
0
5
22
2.29
1.04
1.4
2.0
—
—
—
0
0
7
34
2.08
1.03
2.1
2.3
11.11
4.50
umol/l
—
7
27
52
409
1.33
1.03
4.4
4.4
23.49
21.98
%
0.29
29
198
19
123
1.58
1.02
8.3
12.7
15.89
16.07
%
0.10
19
115
15
92
1.66
0.99
1.1
1.4
76.65
249.78
miu/ml
—
6
46
77
643
1.27
0.98
2.7
2.2
—
—
—
0
0
9
50
1.82
0.97
1.7
2.7
18.33
16.10
%
—
9
50
54
431
1.31
0.97
1.7
1.5
—
—
—
0
0
12
70
1.74
0.94
19.1
3.3
1.66
1.41
mg/l
0.55
12
59
6
27
2.25
0.94
1.2
1.2
—
—
—
0
0
62
508
1.28
0.92
4.7
3.9
791.00
260.65
ng/l
0.49
43
391
10
56
1.81
0.89
1.7
1.3
—
—
—
0
0
6
30
2.02
0.87
1.0
1.5
—
—
—
0
0
22
154
1.46
0.86
3.0
3.3
4.34
4.47
pmol/l
0.31
17
136
6
31
1.95
0.85
1.0
1.5
—
—
—
0
0
6
31
1.95
0.85
1.0
1.5
—
—
—
0
0
6
31
1.95
0.85
1.2
1.2
—
—
—
0
0
33
251
1.35
0.83
6.4
9.8
121.36
120.37
g/l
0.11
33
243
6
32
1.89
0.82
3.0
1.3
—
—
—
0
0
6
33
1.83
0.79
2.5
1.4
—
—
—
0
0
5
24
2.10
0.75
1.2
1.2
—
—
—
0
0
5
24
2.10
0.75
2.4
1.8
—
—
—
0
0
40
319
1.29
0.74
3.4
3.0
0.62
0.86
ug/l
1.30
25
211
5
25
2.02
0.73
1.2
1.2
—
—
—
0
0
5
26
1.94
0.71
1.2
1.2
—
—
—
0
0
5
26
1.94
0.71
1.2
1.2
—
—
—
0
0
7
42
1.68
0.69
2.6
1.7
—
—
—
0
0
5
27
1.87
0.68
1.0
1.0
—
—
—
0
0
55
462
1.23
0.68
1.9
1.8
1186.08
1216.54
nmol/l
0.11
48
339
73
632
1.21
0.67
5.7
4.0
1.02
1.02
kg/l
0.16
46
428
53
445
1.23
0.66
4.0
2.9
3.89
3.42
e6/l
0.11
28
201
5
29
1.74
0.64
1.0
1.6
—
—
—
0
0
5
29
1.74
0.64
1.0
1.1
—
—
—
0
0
5
29
1.74
0.64
1.0
1.6
—
—
—
0
0
5
30
1.68
0.61
1.0
1.5
—
—
—
0
0
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
22
167
1.34
0.58
5.6
9.5
24.42
24.58
mmol/l
0.08
22
158
6
37
1.63
0.56
1.8
1.8
—
—
—
0
0
18
236
0.75
0.53
2.3
2.0
3.31
3.44
ratio
0.21
18
192
15
109
1.40
0.52
1.7
1.6
0.65
0.33
mg/l
—
6
47
14
101
1.41
0.50
2.6
2.0
13966.50
6216.21
u/l
—
5
37
10
67
1.51
0.50
1.2
1.4
—
—
—
0
0
10
67
1.51
0.50
1.7
1.1
—
6.58
—
0
12
38
322
1.21
0.45
2.6
2.2
—
—
—
0
0
16
121
1.34
0.45
3.6
8.5
1.38
1.58
%
0.69
16
109
55
485
1.16
0.43
3.7
2.7
0.68
1.21
e6/l
1.29
29
239
0
15
0.00
0.41
0.0
1.1
—
112.72
—
0
15
8
59
1.37
0.41
3.0
1.5
—
—
—
0
0
0
17
0.00
0.41
0.0
1.9
—
7.42
—
0
17
109
1012
1.12
0.40
5.6
3.8
30.40
69.44
ng/l
0.61
74
735
0
19
0.00
0.39
0.0
3.8
—
0.63
—
0
19
5
37
1.36
0.37
1.8
1.4
—
—
—
0
0
9
70
1.29
0.37
1.9
1.2
—
—
—
0
0
6
44
1.37
0.34
1.3
1.5
24.63
21.02
u/l
—
6
36
19
155
1.24
0.33
1.8
1.8
—
—
—
0
0
26
301
0.85
0.29
3.4
4.8
29.44
32.19
%
0.79
16
194
33
295
1.13
0.23
2.5
2.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
32
288
1.12
0.21
2.8
4.6
10.52
25.98
ug/l
0.48
24
242
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
12
99
1.22
0.20
3.0
2.0
—
—
—
0
0
6
80
0.74
0.15
1.3
1.4
—
—
—
0
0
7
87
0.80
0.14
1.3
2.4
24.30
24.64
mmol/l
—
7
87
11
93
1.19
0.14
2.9
1.8
—
—
—
0
0
10
84
1.20
0.14
1.8
2.1
—
—
—
0
0
82
792
1.05
0.11
2.0
1.7
17.83
20.96
nmol/l
1.51
75
667
10
87
1.15
0.09
1.0
1.1
0.92
0.86
g/l
—
10
87
6
72
0.83
0.07
3.8
1.7
—
—
—
0
0
8
75
1.07
0.07
1.8
1.2
—
—
—
0
0
32
304
1.06
0.07
6.6
8.7
5.18
5.14
kpa
0.10
32
289
32
304
1.06
0.07
6.7
8.7
11.30
12.62
kpa
0.95
32
291
7
85
0.82
0.07
1.6
2.0
42.29
311.29
ug/l
—
7
79
29
282
1.03
0.02
13.0
7.1
—
—
—
0
0
14
134
1.05
0.00
1.2
1.4
—
—
—
0
0
19
187
1.02
0.00
1.9
1.4
—
—
—
0
0
17
175
0.97
0.00
3.5
2.8
47.00
56.87
u/ml
0.14
17
170
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
5
57
0.88
-0.00
1.2
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
32.83
—
0
8
8
86
0.93
-0.00
1.0
1.1
1.39
1.57
g/l
—
8
86
Mortality – FinRegistry
↥Association
Association between endpoint H7_DACRYOADENITIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_DACRYOADENITIS | 1.049 [0.86, 1.27] | 0.633 |
| Birth year | 0.995 [0.99, 1.0] | 0.239 |
During the follow-up period (1.1.1998 — 31.12.2019), 219 out of 1134 females with H7_DACRYOADENITIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_DACRYOADENITIS | 1.041 [0.76, 1.42] | 0.798 |
| Birth year | 0.984 [0.97, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 98 out of 509 males with H7_DACRYOADENITIS died.
Mortality risk
Mortality risk for people of age
years, who have H7_DACRYOADENITIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.087% | 0.212% |
| 5 | 0.568% | 1.1% |
| 10 | 1.448% | 2.794% |
| 15 | 2.876% | 5.216% |
| 20 | 5.457% | 8.913% |
Relationships between endpoints
↥Index endpoint: H7_DACRYOADENITIS – Dacryoadenitis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data